Frontiers in Oncology | Hematologic Malignancies

Systematic Review

Accepted on 16 Jan 2025

Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis

in Hematologic Malignancies

Hongbin Lu
Lulu Luo
Jie Mi
Min Sun
Huaping Wang
Zheng Wang
Wenwen Ding

Frontiers in Oncology

doi 10.3389/fonc.2025.1506799

Brief Research Report

Accepted on 16 Jan 2025

A novel truncated fusion gene ETV6::AC010198.2 in post-MPN acute myeloid leukemia caused by del(12)(p13p11)

in Hematologic Malignancies

Jiao Lu
Zheng Wang
Guanqun Yang
Wang Man
Lijun Wang
Lu Chen
Haoyue Chen
Xin Jiang
Chunhua Liu
Tong Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1495182

Review

Published on 16 Jan 2025

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma

in Hematologic Malignancies

Hong Yan
Nan Jiang
Xiaoying Li
Chenyang Lin
Fang Wang
Juan Zhang
Lijuan Chen
Dan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1522491

177 views

Case Report

Accepted on 13 Jan 2025

Unusual Symptoms Reveal a Rare Splenic Lymphoma: A Case Report of PS-DLBCL with Neck and Shoulder Pain as the Initial Presentation

in Hematologic Malignancies

Shifu Hu
Yuanyuan Hao
Xiangyu Liu
Hanbo Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1449966

Case Report

Accepted on 13 Jan 2025

Daratumumab treatment for kidney-involved light chain deposition disease prevents renal function progression: A case report with 3 years of follow-up and review of the literature

in Hematologic Malignancies

Xueying Chen
jie sun
Pingyan Shen
Zijin Chen
Wen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1466323

Original Research

Published on 07 Jan 2025

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study

in Hematologic Malignancies

Zhiqiang Zhao
Qinchuan Yu
Liping Su
Jianxia He
Jie Tao
Yanfeng Xi
Yujiao Guo
Yanhong Luo
Lieyang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1494384

193 views

Systematic Review

Published on 07 Jan 2025

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis

in Hematologic Malignancies

Jile Liu
Yuxin An
Rui Sun
Xiaomei Zhang
Shujing Guo
Xuejin Gao
Mingfeng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1478888

296 views

Original Research

Published on 07 Jan 2025

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML

in Hematologic Malignancies

Petra Bašová
Lubomír Minařík
Silvia Carina Magalhaes-Novais
Jana Balounová
Zuzana Zemanová
Tatiana Aghová
Martin Špaček
Anna Jonášová
Kristýna Gloc Pimková
Jan Procházka

Frontiers in Oncology

doi 10.3389/fonc.2024.1414950

286 views

Original Research

Accepted on 06 Jan 2025

"Cresp®: Transforming the Landscape of Chemotherapy-Induced Anemia -A Comprehensive Retrospective Real-World Analysis in 523 Indian Patients"

in Hematologic Malignancies

Chandrakanth M V
Vivek Agarwala
Pranav Sopory
Himadri Nayak
Purvish M Parikh
Minakshi Roy
Rajib De
Pradeep Narayan
Anjuli Tuladhar Barai
Kaustav Mandal

Frontiers in Oncology

doi 10.3389/fonc.2025.1418327

Original Research

Accepted on 06 Jan 2025

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms

in Hematologic Malignancies

Esther Natalie Oliva
Shien Guo
Jennifer Lord-Bessen
Aylin Yucel
Roberto Latagliata
Massimo Breccia
Giuseppe A. Palumbo
Grazia Sanpaolo
Marta Riva
Valeria Santini

Frontiers in Oncology

doi 10.3389/fonc.2025.1507854

Editorial

Published on 06 Jan 2025

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II

in Hematologic Malignancies

Lokman Varisli
Garrett M. Dancik
John A. Copland
Spiros A. Vlahopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1542306

227 views

Original Research

Published on 06 Jan 2025

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes

in Hematologic Malignancies

Lisa Dietsche
Kristin Stirm
Veronika Lysenko
Corina Schneidawind
Alexandar Tzankov
Anne Müller
Alexandre P. A. Theocharides

Frontiers in Oncology

doi 10.3389/fonc.2024.1481713

261 views

Original Research

Published on 06 Jan 2025

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma

in Hematologic Malignancies

Dan Liu
Xia Yin
Hui Wang
Lijie Xing
Ping Li
Haichen Wei
Ji Ma
Qiang He
Linna Xie
Ke Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1504809

227 views

Original Research

Published on 06 Jan 2025

Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit

in Hematologic Malignancies

Panagiotis Karagiannis
Felix Klingler
Viktor Arelin
Winfried Alsdorf
Christina König
Kevin Roedl
Walter Fiedler
Katja Weisel
Stefan Kluge
Carsten Bokemeyer

Frontiers in Oncology

doi 10.3389/fonc.2024.1508112

230 views

Case Report

Published on 06 Jan 2025

Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area

in Hematologic Malignancies

Xiping Yu
Houyun Xu
Junjie Zhou
Zhiqiang Zhu
Baizhou Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1407893

148 views

Review

Accepted on 30 Dec 2024

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies

in Hematologic Malignancies

Mariam Markouli
Maria Pagoni
Panagiotis Diamantopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1501950

Navigation group

Articles

Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis

A novel truncated fusion gene ETV6::AC010198.2 in post-MPN acute myeloid leukemia caused by del(12)(p13p11)

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma

Unusual Symptoms Reveal a Rare Splenic Lymphoma: A Case Report of PS-DLBCL with Neck and Shoulder Pain as the Initial Presentation

Daratumumab treatment for kidney-involved light chain deposition disease prevents renal function progression: A case report with 3 years of follow-up and review of the literature

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML

"Cresp®: Transforming the Landscape of Chemotherapy-Induced Anemia -A Comprehensive Retrospective Real-World Analysis in 523 Indian Patients"

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma

Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit

Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies